AT380694B - Verfahren zur herstellung von mikroorganismen - Google Patents

Verfahren zur herstellung von mikroorganismen

Info

Publication number
AT380694B
AT380694B AT0410381A AT410381A AT380694B AT 380694 B AT380694 B AT 380694B AT 0410381 A AT0410381 A AT 0410381A AT 410381 A AT410381 A AT 410381A AT 380694 B AT380694 B AT 380694B
Authority
AT
Austria
Prior art keywords
producing microorganisms
microorganisms
producing
Prior art date
Application number
AT0410381A
Other languages
English (en)
Other versions
ATA410381A (de
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26886463&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AT380694(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of ATA410381A publication Critical patent/ATA410381A/de
Application granted granted Critical
Publication of AT380694B publication Critical patent/AT380694B/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C07K14/565—IFN-beta
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT0410381A 1980-09-25 1981-09-24 Verfahren zur herstellung von mikroorganismen AT380694B (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US19079980A 1980-09-25 1980-09-25
US29189281A 1981-08-11 1981-08-11

Publications (2)

Publication Number Publication Date
ATA410381A ATA410381A (de) 1985-11-15
AT380694B true AT380694B (de) 1986-06-25

Family

ID=26886463

Family Applications (1)

Application Number Title Priority Date Filing Date
AT0410381A AT380694B (de) 1980-09-25 1981-09-24 Verfahren zur herstellung von mikroorganismen

Country Status (33)

Country Link
US (1) US5460811A (de)
EP (1) EP0048970A3 (de)
AT (1) AT380694B (de)
AU (1) AU582110B2 (de)
BR (1) BR8106137A (de)
CA (1) CA1341569C (de)
CH (2) CH651309A5 (de)
DD (3) DD209477A5 (de)
DE (1) DE3138096A1 (de)
DK (1) DK423381A (de)
ES (3) ES505742A0 (de)
FI (1) FI812993L (de)
FR (1) FR2490675B1 (de)
GB (1) GB2098996B (de)
GR (1) GR81946B (de)
HK (1) HK43686A (de)
IE (1) IE51679B1 (de)
IL (1) IL63916A0 (de)
IT (1) IT1139487B (de)
KE (1) KE3630A (de)
LU (1) LU83648A1 (de)
MC (1) MC1423A1 (de)
MT (1) MTP900B (de)
MY (1) MY8600634A (de)
NL (1) NL8104400A (de)
NO (1) NO813248L (de)
NZ (1) NZ198445A (de)
OA (1) OA06908A (de)
PL (1) PL233194A1 (de)
PT (1) PT73728B (de)
SE (1) SE8105657L (de)
YU (1) YU44835B (de)
ZW (1) ZW23981A1 (de)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK33181A (da) * 1980-02-06 1981-08-07 Searle & Co Fremgangsmaade til fremstilling af et interferonlignende protein
ZA811368B (en) * 1980-03-24 1982-04-28 Genentech Inc Bacterial polypedtide expression employing tryptophan promoter-operator
ES500966A0 (es) 1980-04-03 1982-12-16 Biogen Nv Un metodo de producir un polipeptido que muestra una actividad immunologica obiologica de interferon de fibroblasto hu- mano.
EP0042246B1 (de) * 1980-06-12 1987-03-18 The Cancer Institute Of Japanese Foundation For Cancer Research Plasmid
DK489481A (da) * 1980-11-10 1982-05-11 Searle & Co Plasmidvektor og frmgangsmaade til fremstilling deraf
NZ199722A (en) * 1981-02-25 1985-12-13 Genentech Inc Dna transfer vector for expression of exogenous polypeptide in yeast;transformed yeast strain
JPS58110600A (ja) * 1981-12-25 1983-07-01 Kyowa Hakko Kogyo Co Ltd ヒトβ型インタ−フエロン遺伝子を含む組みかえ体プラスミド
US4775622A (en) * 1982-03-08 1988-10-04 Genentech, Inc. Expression, processing and secretion of heterologous protein by yeast
US5827694A (en) * 1982-03-08 1998-10-27 Genentech, Inc. DNA encoding non-human animal interferons, vectors and hosts therefor, and recombinant production of IFN polypeptides
IE54592B1 (en) * 1982-03-08 1989-12-06 Genentech Inc Anumal interferons, processes involved in their production, compositions containing them, dna sequences coding therefor and espression vehicles containing such sequences and cells transformed thereby
US6432677B1 (en) 1982-03-08 2002-08-13 Genentech, Inc. Non-human animal interferons
AU575301B2 (en) * 1982-10-08 1988-07-28 Juridical Foundation, Japanese Foundation For Cancer Research Novel vector
US5831023A (en) * 1982-11-01 1998-11-03 Genentech, Inc. Recombinant animal interferon polypeptides
US4620948A (en) * 1982-12-22 1986-11-04 Genentech, Inc. Purification and activity assurance of precipitated heterologous proteins
US4599197A (en) * 1982-12-22 1986-07-08 Genentech, Inc. Purification and activity assurance of precipitated heterologous proteins
US4511502A (en) * 1982-12-22 1985-04-16 Genentech, Inc. Purification and activity assurance of precipitated heterologous proteins
US4518526A (en) * 1982-12-22 1985-05-21 Genentech, Inc. Purification and activity assurance of precipitated heterologous proteins
GR79124B (de) * 1982-12-22 1984-10-02 Genentech Inc
US4512922A (en) * 1982-12-22 1985-04-23 Genentech, Inc. Purification and activity assurance of precipitated heterologous proteins
US5683688A (en) 1984-05-31 1997-11-04 Genentech, Inc. Unglycosylated recombinant human lymphotoxin polypeptides and compositions
GB8414354D0 (en) * 1984-06-05 1984-07-11 Biogen Nv Purifying protein
US5231176A (en) * 1984-08-27 1993-07-27 Genentech, Inc. Distinct family DNA encoding of human leukocyte interferons
EP0174143B1 (de) * 1984-08-27 1989-11-08 Genentech, Inc. Verschiedenartige Familie von menschlichen Leukozyten-Interferonen, Zusammensetzungen, die diese enthalten, Verfahren zu ihrer Herstellung, sowie DNA und transfektierte Wirte hierfür
US4680262A (en) * 1984-10-05 1987-07-14 Genentech, Inc. Periplasmic protein recovery
US5618920A (en) 1985-11-01 1997-04-08 Xoma Corporation Modular assembly of antibody genes, antibodies prepared thereby and use
EP0237019A3 (de) * 1986-03-14 1988-03-09 Toray Industries, Inc. Konjugiertes Interferon und dessen Herstellung unter Verwendung eines rekombinanten Gens
GB9022543D0 (en) * 1990-10-17 1990-11-28 Wellcome Found Antibody production
FR2686899B1 (fr) 1992-01-31 1995-09-01 Rhone Poulenc Rorer Sa Nouveaux polypeptides biologiquement actifs, leur preparation et compositions pharmaceutiques les contenant.
US20050002902A1 (en) * 1995-12-28 2005-01-06 Liming Yu Hybrid with interferon-alpha and an immunoglobulin Fc for treatment of tumors and viral infections
US20030026779A1 (en) * 1999-10-15 2003-02-06 Liming Yu Treatment of tumors and viral infections with a hybrid conjugate of interferon and an immunoglobulin Fc
US5723125A (en) * 1995-12-28 1998-03-03 Tanox Biosystems, Inc. Hybrid with interferon-alpha and an immunoglobulin Fc linked through a non-immunogenic peptide
US6713609B1 (en) * 1996-07-16 2004-03-30 Genentech, Inc. Monoclonal antibodies to type I interferon receptor
JP3576819B2 (ja) 1997-07-30 2004-10-13 キヤノン株式会社 情報処理装置及び印刷制御方法並びに記憶媒体
US20030018174A1 (en) * 1997-10-06 2003-01-23 Genentech, Inc. Monoclonal antibodies to IFNAR2
EP1165835A2 (de) 1999-03-24 2002-01-02 Serono Genetics Institute S.A. Genomische sequenz des purh genes und der purh-bezogenen biallelischen markers
AU2001259063A1 (en) 2000-04-12 2001-10-30 Human Genome Sciences, Inc. Albumin fusion proteins
BR0206364A (pt) * 2001-01-09 2005-08-16 Baylor Res Inst Métodos para tratar doenças auto-imunes em um indivìduo e testes diagnósticos in vitro
WO2005003296A2 (en) 2003-01-22 2005-01-13 Human Genome Sciences, Inc. Albumin fusion proteins
EP1463751B1 (de) 2001-12-21 2013-05-22 Human Genome Sciences, Inc. Albuminfusionsproteine
KR101271635B1 (ko) * 2001-12-21 2013-06-12 휴먼 게놈 사이언시즈, 인코포레이티드 알부민 융합 단백질
BR0317752A (pt) * 2002-12-26 2005-11-22 Mountain View Pharmaceuticals Conjugados poliméricos de citocinas, quimiocinas, fatores do crescimento, hormÈnios polipeptìdicos e seus antagonistas com atividade de ligação a receptores conservada
EA008866B1 (ru) 2002-12-26 2007-08-31 Маунтин Вью Фамэсьютикэлс, Инк. ПОЛИМЕРНЫЙ КОНЪЮГАТ МОДИФИКАЦИЙ ИНТЕРФЕРОНА-β, ФАРМАЦЕВТИЧЕСКИЕ ПРОДУКТЫ НА ЕГО ОСНОВЕ И СПОСОБ ИХ ПОЛУЧЕНИЯ
SG135176A1 (en) 2004-02-02 2007-09-28 Ambrx Inc Modified human four helical bundle polypeptides and their uses
AU2009212311B8 (en) 2004-07-21 2013-05-30 Ambrx, Inc. Modified leptin polypeptides and their uses
CA2612378A1 (en) * 2005-06-22 2007-01-04 Genentech, Inc. Methods and compositions for targeting ifnar2

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT373279B (de) * 1977-11-08 1984-01-10 Genentech Inc Verfahren zur herstellung eines rekombinationsclonbildungstraegers
US4411994A (en) * 1978-06-08 1983-10-25 The President And Fellows Of Harvard College Protein synthesis
IN150740B (de) * 1978-11-24 1982-12-04 Hoffmann La Roche
US4332892A (en) * 1979-01-15 1982-06-01 President And Fellows Of Harvard College Protein synthesis
US4262090A (en) * 1979-06-04 1981-04-14 Cetus Corporation Interferon production
US4342832A (en) * 1979-07-05 1982-08-03 Genentech, Inc. Method of constructing a replicable cloning vehicle having quasi-synthetic genes
US4289689A (en) * 1980-03-14 1981-09-15 Hoffmann-La Roche Inc. Preparation of homogeneous human fibroblast interferon
CH648331A5 (de) * 1979-07-31 1985-03-15 Hoffmann La Roche Homogenes fibroblasten-interferon und dessen herstellung.
AU538665B2 (en) * 1979-10-30 1984-08-23 Juridical Foundation, Japanese Foundation For Cancer Research Human interferon dna
IL58765A (en) * 1979-11-21 1986-09-30 Yeda Res & Dev Process for the production of essentially pure messenger rna of human fibroblast interferon and process for the production of interferon beta
US4418149A (en) * 1980-01-10 1983-11-29 President And Fellows Of Harvard College Fused hybrid gene
DK33181A (da) * 1980-02-06 1981-08-07 Searle & Co Fremgangsmaade til fremstilling af et interferonlignende protein
GB2068970B (en) * 1980-02-06 1983-06-22 Searle & Co Recombinant dna technique for the preparation of a protein resembling human interferon
DE3005843A1 (de) * 1980-02-16 1981-09-10 Hoechst Ag, 6000 Frankfurt Genprodukt eines hoeheren organismus aus einem dieses gen enthaltenden mikroorganismus
ES500966A0 (es) * 1980-04-03 1982-12-16 Biogen Nv Un metodo de producir un polipeptido que muestra una actividad immunologica obiologica de interferon de fibroblasto hu- mano.
EP0042246B1 (de) * 1980-06-12 1987-03-18 The Cancer Institute Of Japanese Foundation For Cancer Research Plasmid
US4874702A (en) * 1980-09-08 1989-10-17 Biogen, Inc. Vectors and methods for making such vectors and for expressive cloned genes

Also Published As

Publication number Publication date
PT73728B (en) 1984-05-08
PT73728A (en) 1981-10-01
NO813248L (no) 1982-03-26
CH651309A5 (de) 1985-09-13
KE3630A (en) 1986-05-16
AU582110B2 (en) 1989-03-16
GB2098996B (en) 1985-02-06
SE8105657L (sv) 1982-03-26
IT1139487B (it) 1986-09-24
OA06908A (fr) 1983-05-31
ES8307297A1 (es) 1983-07-01
CH656388A5 (de) 1986-06-30
FR2490675A1 (fr) 1982-03-26
NZ198445A (en) 1984-05-31
IE51679B1 (en) 1987-02-04
YU229781A (en) 1984-02-29
DK423381A (da) 1982-03-26
FI812993L (fi) 1982-03-26
DD209652A5 (de) 1984-05-16
ES8306325A1 (es) 1983-06-01
AU7564981A (en) 1982-04-01
IL63916A0 (en) 1981-12-31
IE812224L (en) 1982-03-25
DD202085A5 (de) 1983-08-24
GB2098996A (en) 1982-12-01
CA1341569C (en) 2008-03-25
FR2490675B1 (fr) 1985-11-15
MY8600634A (en) 1986-12-31
ATA410381A (de) 1985-11-15
GR81946B (de) 1984-12-12
ES505742A0 (es) 1983-07-01
DD209477A5 (de) 1984-05-09
DE3138096A1 (de) 1982-06-09
US5460811A (en) 1995-10-24
YU44835B (en) 1991-04-30
ES8306324A1 (es) 1983-06-01
EP0048970A3 (de) 1982-08-18
IT8124109A0 (it) 1981-09-23
ES515032A0 (es) 1983-06-01
ES515033A0 (es) 1983-06-01
PL233194A1 (en) 1983-07-18
EP0048970A2 (de) 1982-04-07
LU83648A1 (de) 1983-06-08
HK43686A (en) 1986-06-20
ZW23981A1 (en) 1982-04-28
BR8106137A (pt) 1982-06-15
MTP900B (en) 1985-02-28
MC1423A1 (fr) 1982-10-18
NL8104400A (nl) 1982-04-16

Similar Documents

Publication Publication Date Title
AT380272B (de) Verfahren zur herstellung von mikroorganismen
AT380694B (de) Verfahren zur herstellung von mikroorganismen
AT382796B (de) Verfahren zur herstellung von mikrokapseln
DE3486188D1 (de) Verfahren zur herstellung von l-tyrosin.
AT379615B (de) Verfahren zur herstellung von l-carnitin
DE3586516D1 (de) Verfahren zur herstellung von maleimiden.
DE3177254D1 (de) Verfahren zur herstellung von koerpern.
AT380672B (de) Verfahren zur kontinuierlichen herstellung von mesokohlenstoff-mikroperlen
AT376919B (de) Verfahren zur herstellung geformter gegenstaende
AT374827B (de) Verfahren zur herstellung von cholesterase
DE3382369D1 (de) Verfahren zur herstellung von blockcopolyamiden.
AT367436B (de) Verfahren zur herstellung von copolymerisaten
AT372675B (de) Verfahren zur herstellung von alpha-cyanophenoxybenzylestern
AT380686B (de) Verfahren zur herstellung von buspiron
AT372676B (de) Verfahren zur herstellung von alpha-cyanophenoxybenzylestern
AT375328B (de) Verfahren zur herstellung von sintermagnesia
DE3580463D1 (de) Verfahren zur herstellung von l-serine.
ATA110780A (de) Verfahren zur herstellung von o-trimethylsilyl- -cellulosen
AT373260B (de) Verfahren zur herstellung von halbsynthetischen penicillinen
AT375398B (de) Verfahren zur bildung von uricase durch mikroorganismen
AT378184B (de) Verfahren zur herstellung von 4-amino-1,2hydrocarbyl-pyrazolidinen
AT375083B (de) Verfahren zur herstellung von 1alfa,25-dihydroxycholesterin
ATA558180A (de) Verfahren zur herstellung von cellulosehaeltigen biomassen
DE3874961D1 (de) Verfahren zur herstellung von endo-alpha-n-acetylgalactosaminidase durch mikroorganismen.
AT370716B (de) Verfahren zur herstellung von naphthacendionderivaten

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee
EFA Change in the company name